These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 17989111

  • 1. Purinergic receptors contribute to early mesangial cell transformation and renal vessel hypertrophy during angiotensin II-induced hypertension.
    Graciano ML, Nishiyama A, Jackson K, Seth DM, Ortiz RM, Prieto-Carrasquero MC, Kobori H, Navar LG.
    Am J Physiol Renal Physiol; 2008 Jan; 294(1):F161-9. PubMed ID: 17989111
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Purinergic P2X1 receptor, purinergic P2X7 receptor, and angiotensin II type 1 receptor interactions in the regulation of renal afferent arterioles in angiotensin II-dependent hypertension.
    Kulthinee S, Shao W, Franco M, Navar LG.
    Am J Physiol Renal Physiol; 2020 Jun 01; 318(6):F1400-F1408. PubMed ID: 32308022
    [Abstract] [Full Text] [Related]

  • 5. Impaired Ca2+ signaling attenuates P2X receptor-mediated vasoconstriction of afferent arterioles in angiotensin II hypertension.
    Zhao X, Cook AK, Field M, Edwards B, Zhang S, Zhang Z, Pollock JS, Imig JD, Inscho EW.
    Hypertension; 2005 Sep 01; 46(3):562-8. PubMed ID: 16116048
    [Abstract] [Full Text] [Related]

  • 6. Clopidogrel, independent of the vascular P2Y12 receptor, improves arterial function in small mesenteric arteries from AngII-hypertensive rats.
    Giachini FR, Osmond DA, Zhang S, Carneiro FS, Lima VV, Inscho EW, Webb RC, Tostes RC.
    Clin Sci (Lond); 2010 Apr 01; 118(7):463-71. PubMed ID: 19811450
    [Abstract] [Full Text] [Related]

  • 7. Anti-platelet therapy with clopidogrel prevents endothelial dysfunction and vascular remodeling in aortas from hypertensive rats.
    Giachini FR, Leite R, Osmond DA, Lima VV, Inscho EW, Webb RC, Tostes RC.
    PLoS One; 2014 Apr 01; 9(3):e91890. PubMed ID: 24638017
    [Abstract] [Full Text] [Related]

  • 8. P2 receptor antagonist PPADS inhibits mesangial cell proliferation in experimental mesangial proliferative glomerulonephritis.
    Rost S, Daniel C, Schulze-Lohoff E, Bäumert HG, Lambrecht G, Hugo C.
    Kidney Int; 2002 Nov 01; 62(5):1659-71. PubMed ID: 12371966
    [Abstract] [Full Text] [Related]

  • 9. Interaction of Angiotensin II AT1 Receptors with Purinergic P2X Receptors in Regulating Renal Afferent Arterioles in Angiotensin II-Dependent Hypertension.
    Kulthinee S, Tasanarong A, Franco M, Navar LG.
    Int J Mol Sci; 2023 Jul 13; 24(14):. PubMed ID: 37511174
    [Abstract] [Full Text] [Related]

  • 10. P2X(1) receptor blockade inhibits whole kidney autoregulation of renal blood flow in vivo.
    Osmond DA, Inscho EW.
    Am J Physiol Renal Physiol; 2010 Jun 13; 298(6):F1360-8. PubMed ID: 20335318
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Role of renal nerves in afferent arteriolar reactivity in angiotensin-induced hypertension.
    Ichihara A, Inscho EW, Imig JD, Michel RE, Navar LG.
    Hypertension; 1997 Jan 13; 29(1 Pt 2):442-9. PubMed ID: 9039140
    [Abstract] [Full Text] [Related]

  • 15. Integration of purinergic and angiotensin II receptor function in renal vascular responses and renal injury in angiotensin II-dependent hypertension.
    Franco M, Pérez-Méndez O, Kulthinee S, Navar LG.
    Purinergic Signal; 2019 Jun 13; 15(2):277-285. PubMed ID: 31183668
    [Abstract] [Full Text] [Related]

  • 16. Maintained tubuloglomerular feedback responses during acute inhibition of P2 purinergic receptors in mice.
    Schnermann J.
    Am J Physiol Renal Physiol; 2011 Feb 13; 300(2):F339-44. PubMed ID: 21147842
    [Abstract] [Full Text] [Related]

  • 17. Ang II accumulation in rat renal endosomes during Ang II-induced hypertension: role of AT(1) receptor.
    Zhuo JL, Imig JD, Hammond TG, Orengo S, Benes E, Navar LG.
    Hypertension; 2002 Jan 13; 39(1):116-21. PubMed ID: 11799089
    [Abstract] [Full Text] [Related]

  • 18. Renal injury from angiotensin II-mediated hypertension.
    Johnson RJ, Alpers CE, Yoshimura A, Lombardi D, Pritzl P, Floege J, Schwartz SM.
    Hypertension; 1992 May 13; 19(5):464-74. PubMed ID: 1568765
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Enhancement of angiotensinogen expression in angiotensin II-dependent hypertension.
    Kobori H, Harrison-Bernard LM, Navar LG.
    Hypertension; 2001 May 13; 37(5):1329-35. PubMed ID: 11358949
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.